Kynam Capital discloses 1.49M enGene (ENGN) shares stake

Rhea-AI Filing Summary

Kynam Capital Management and related reporting persons disclose a 2.23% beneficial stake in enGene Holdings Inc. common shares on an amended Schedule 13G. They report beneficial ownership of 1,492,898 common shares, with shared voting and dispositive power and no sole voting or dispositive authority.

The filing names Kynam Capital Management, LP, Kynam Capital Management GP, LLC, and Yue Tang as reporting persons and certifies the shares are held in the ordinary course of business, not for the purpose of changing or influencing control of enGene.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

enGene Holdings Inc.

(Name of Issuer)

Common Shares, no par value per share

(Title of Class of Securities)

29286M105

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 29286M105

1

Names of Reporting Persons

Kynam Capital Management, LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,492,898.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,492,898.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,492,898.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.23 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. 29286M105

1

Names of Reporting Persons

Kynam Capital Management GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,492,898.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,492,898.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,492,898.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.23 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 29286M105

1

Names of Reporting Persons

Yue Tang

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,492,898.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,492,898.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,492,898.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.23 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: enGene Holdings Inc.
(b)	Address of issuer's principal executive offices: 4868 RUE LEVY, SUITE 220, SAINT-LAURENT, QUEBEC, CANADA H4R 2P1
Item 2.
(a)	Name of person filing: Kynam Capital Management, LP Kynam Capital Management GP, LLC Yue Tang
(b)	Address or principal business office or, if none, residence: 221 ELM ROAD PRINCETON, New Jersey 08540
(c)	Citizenship: Kynam Capital Management, LP - DELAWARE Kynam Capital Management GP, LLC - DELAWARE Yue Tang - UNITED STATES
(d)	Title of class of securities: Common Shares, no par value per share
(e)	CUSIP No.: 29286M105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,492,898
(b)	Percent of class: 2.23 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Kynam Capital Management, LP - 0 Kynam Capital Management GP, LLC - 0 Yue Tang - 0
	(ii) Shared power to vote or to direct the vote: Kynam Capital Management, LP - 1,492,898 Kynam Capital Management GP, LLC - 1,492,898 Yue Tang - 1,492,898
	(iii) Sole power to dispose or to direct the disposition of: Kynam Capital Management, LP - 0 Kynam Capital Management GP, LLC - 0 Yue Tang - 0
	(iv) Shared power to dispose or to direct the disposition of: Kynam Capital Management, LP - 1,492,898 Kynam Capital Management GP, LLC - 1,492,898 Yue Tang - 1,492,898
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Kynam Capital Management, LP

Signature:	Yue Tang
Name/Title:	Managing Member
Date:	02/17/2026

Kynam Capital Management GP, LLC

Signature:	Yue Tang
Name/Title:	Managing Member
Date:	02/17/2026

Yue Tang

Signature:	Yue Tang
Name/Title:	Self
Date:	02/17/2026

FAQ

What ownership stake in enGene (ENGN) does Kynam Capital report?

Kynam Capital and related reporting persons report beneficial ownership of 1,492,898 enGene common shares, representing 2.23% of the class. This stake is held with shared voting and dispositive power, and falls below the 5% threshold that typically triggers larger-holder reporting.

Who are the reporting persons in this enGene (ENGN) Schedule 13G/A?

The filing lists Kynam Capital Management, LP, Kynam Capital Management GP, LLC, and Yue Tang as reporting persons. Each reports the same 1,492,898 shares with shared voting and dispositive power, and no sole voting or sole dispositive authority over the enGene common shares.

Does Kynam Capital have sole voting power over its enGene (ENGN) shares?

No. The Schedule 13G/A reports 0 shares with sole voting power for each reporting person. All 1,492,898 enGene common shares are reported as subject to shared voting and shared dispositive power, reflecting joint authority rather than unilateral control by any one reporting person.

Is Kynam Capital’s enGene (ENGN) position intended to influence control of the company?

The certification states the securities were acquired and are held in the ordinary course of business, not for the purpose or effect of changing or influencing control of enGene. It also notes they are not held in connection with any transaction having that control-related purpose or effect.

Why is this enGene (ENGN) ownership reported on Schedule 13G/A instead of 13D?

Schedule 13G is used for passive beneficial ownership, where investors do not seek to influence control. The filing’s certification confirms the enGene shares are held in the ordinary course of business and not to change or influence control, which aligns with Schedule 13G reporting requirements.